MetLife (MET) Director Gutierrez Receives 562 Shares in Form 4 Filing
MetLife, Inc. (MET) filed a Form 4 reporting routine insider activity by non-management director Carlos M. Gutierrez.
Rhea-AI Filing Summary
MetLife, Inc. (MET) filed a Form 4 reporting routine insider activity by non-management director Carlos M. Gutierrez. On 06/17/2025, Gutierrez received 562 shares of common stock (transaction code A) at a stated price of $0, reflecting the company’s policy to pay a portion of director retainers in equity. Following the grant, the director now owns 23,851 shares directly and 18,807 shares indirectly through the Carlos M. Gutierrez Trust. No derivative securities were involved, and the filing contains no sales or dispositions.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine equity grant; immaterial to MET’s valuation.
This Form 4 reflects a standard director retainer paid in stock—562 shares worth roughly mid-four figures at current prices. The grant modestly increases insider alignment but is far too small to affect float, earnings, or governance risk. No red flags: no sales, no derivatives, no 10b5-1 plan disclosures. Investors should view the filing as an administrative update rather than a signal of strategic intent.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 562 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
FAQ
What is the transaction code listed in the Form 4 for MET?
What are Gutierrez’s total MetLife holdings after the transaction?
Does the Form 4 include any derivative security activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.